Thank you! Your submission has been received!
Oops! Something went wrong while submitting the form.
Dr. Timothy Mackey, Medical Director of NovaGenix

Is Long-Term Testosterone Therapy Safe? Benefits, Risks and Monitoring

November 7, 2024

A physician-guided review of long-term TRT safety, including cardiovascular and prostate evidence, fertility, hematocrit, blood pressure, side effects and monitoring.

Read More
FDA tirzepatide shortage resolution and compounded medication rules

Tirzepatide Shortage Ended: What the FDA Rules Mean Now

October 14, 2024

A physician-reviewed 2026 update on the end of the tirzepatide shortage, FDA compounding rules, 503A and 503B restrictions, individualized prescriptions and what patients should know now.

Read More
Patient considering long-term semaglutide or tirzepatide treatment for weight management

Do You Need to Be on a GLP-1 Agonist Medication Like Wegovy, Ozempic or Mounjaro for Life?

October 3, 2024

A physician-reviewed guide to long-term GLP-1 treatment, including weight regain after stopping semaglutide or tirzepatide, maintenance therapy, lifestyle support and when discontinuation may be reasonable.

Read More
Dr. Timothy Mackey, Medical Director at NovaGenix

Testosterone’s Impact on Muscle Growth and Fat Loss

September 10, 2024

What testosterone studies show about lean mass and body fat, how TRT differs from performance enhancement, and why diagnosis, training and nutrition matter.

Read More
GLP-1 medications used for obesity and diabetes treatment

Ozempic, Wegovy, and Mounjaro: Weighing the Benefits and Risks of GLP-1 Agonists

September 18, 2024

A physician-reviewed overview of GLP-1 medication benefits and risks, including semaglutide, tirzepatide, common side effects, serious warnings, muscle preservation and who may or may not be a good candidate.

Read More

Tesamorelin vs. HGH: How Are They Different?

August 27, 2024

Tesamorelin and HGH affect the growth hormone–IGF-1 axis differently. Compare mechanisms, approved uses, evidence, safety, and monitoring in this physician-reviewed guide.

Read More
Enclomiphene versus Clomid for men with low testosterone

Enclomiphene vs. Clomid for Men: Evidence, Risks and Fertility

August 20, 2024

A physician-reviewed comparison of enclomiphene and clomiphene (Clomid) for men with secondary hypogonadism, including testosterone, fertility, safety and treatment limitations.

Read More

The Relationship Between Testosterone Therapy and Cancer: What You Need to Know

July 22, 2024

Review what prostate studies can and cannot tell us about TRT and cancer, including screening limitations and individual cancer history.

Read More
Dr. Timothy Mackey, Medical Director at NovaGenix

Sports Eligibility and Testosterone Testing: What Athletes Need to Know in 2026

August 6, 2024

Three different questions: category eligibility, anti-doping compliance and medical hormone testing. A practical guide to the 2026 rules and official sources.

Read More

Schedule a Consultation

Learn what you want to know about hormone therapy by scheduling a free consultation.

Contact Us Today
Location pin icon

609 N Hepburn Ave Ste 106, Jupiter, FL 33458